FNY Investment Advisers’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

FNY Investment Advisers’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22K	Hold	700	–	–	0.01%	528
2026 Q1	$20K	Buy	700 +200	+40%	+$5.83K	0.01%	473
2025 Q4	$14K	Buy	+500	New	+$10K	﹤0.01%	615
2022 Q1	–	Hold	0	–	–	–	926
2021 Q4	–	Hold	0	–	–	–	834
2021 Q3	–	Hold	0	–	–	–	937
2021 Q2	–	Hold	0	–	–	–	985
2021 Q1	–	Hold	0	–	–	–	1028

Other funds holding YARW

T3 Companies New York $93.7M AUM

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MLA

MB, Levis & Associates Center Valley, Pennsylvania $271M AUM 15.56% 1-Year Est. Return

FWA

Flagship Wealth Advisors Wakefield, Massachusetts $447M AUM 25.09% 1-Year Est. Return

FNY Investment Advisers's YARW Position: Q2 2026 in Review

FNY Investment Advisers held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q2 2026 at 700 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #528.

FNY Investment Advisers first reported a position in YARW in Q4 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

FNY Investment Advisers held 700 shares of Yarrow Bioscience, Inc. Common Stock worth $22K as of Q2 2026.
FNY Investment Advisers left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q2 2026.
Yarrow Bioscience, Inc. Common Stock made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #528 holding.
FNY Investment Advisers first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
4 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.